相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls
Erik Palsson et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
C. Yang et al.
TRANSLATIONAL PSYCHIATRY (2015)
D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression
Ruin Moaddel et al.
PSYCHOPHARMACOLOGY (2015)
Targeting of NMDA receptors in new treatments for schizophrenia
Kenji Hashimoto
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Blood D-serine levels as a predictive biomarker for the rapid antidepressant effects of the NMDA receptor antagonist ketamine
Kenji Hashimoto
PSYCHOPHARMACOLOGY (2014)
Rapid antidepressant effects and abuse liability of ketamine
Chun Yang et al.
PSYCHOPHARMACOLOGY (2014)
The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
Kenji Hashimoto
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2014)
Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond
John H. Krystal et al.
BIOLOGICAL PSYCHIATRY (2013)
Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
Kenji Hashimoto et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2013)
A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression
Uriel Heresco-Levy et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
Taisuke Yoshida et al.
PLOS ONE (2012)
Criterion and Construct Validity of the CogState Schizophrenia Battery in Japanese Patients with Schizophrenia
Taisuke Yoshida et al.
PLOS ONE (2011)
Reliability, validity and clinical utility of a Japanese version of the Social Adaptation Self-evaluation Scale as calibrated using the Beck Depression Inventory
Nobuhisa Ueda et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2011)
Emerging role of glutamate in the pathophysiology of major depressive disorder
Kenji Hashimoto
BRAIN RESEARCH REVIEWS (2009)
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Gerard Sanacora et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Increased levels of glutamate in brains from patients with mood disorders
Kenji Hashimoto et al.
BIOLOGICAL PSYCHIATRY (2007)
Correlation between plasma levels of glutamate, alanine and serine with severity of depression
Hideaki Mitani et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms
T Sumiyoshi et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
Simultaneous determination of D- and L-serine in rat brain microdialysis sample using a column-switching HPLC with fluorimetric detection
T Fukushima et al.
BIOMEDICAL CHROMATOGRAPHY (2004)
Decreased serum levels of D-serine in patients with schizophrenia - Evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia
K Hashimoto et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Assessment of social functioning in depression
M Bosc
COMPREHENSIVE PSYCHIATRY (2000)
分享论文
